KFC
ELV icon

Klingenstein Fields & Co’s Elevance Health ELV Stock Holding History

Klingenstein Fields & Co’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-4,115
Closed -$337K – 313
2013
Q2 		$337K Buy
+4,115
New +$308K 0.01% 249

Other funds holding ELV

Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Klingenstein Fields & Co's ELV Position: Q3 2013 in Review

Klingenstein Fields & Co sold out of Elevance Health (ELV) in Q3 2013, closing a stake of 4,115 shares — an estimated $337K sold.

Klingenstein Fields & Co first reported a position in ELV in Q2 2013 and held it in 1 quarter. The position peaked at $337K in Q2 2013. 613 funds tracked by Wall St. Rank hold ELV as of Q3 2013.

  • Klingenstein Fields & Co reported no remaining Elevance Health position as of Q3 2013 after selling out during the quarter.
  • Klingenstein Fields & Co sold 4,115 Elevance Health shares in Q3 2013, an estimated $337K.
  • Klingenstein Fields & Co first reported a position in Elevance Health in Q2 2013 and held it in 1 quarter.
  • Klingenstein Fields & Co's Elevance Health position peaked at $337K in Q2 2013.
  • 613 funds tracked by Wall St. Rank held Elevance Health as of Q3 2013.

Based on Klingenstein Fields & Co's 13F filing for Q3 2013, filed 4 Nov 2013.